Anders Eklúnd

15.2k total citations · 2 hit papers
258 papers, 11.3k citations indexed

About

Anders Eklúnd is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Anders Eklúnd has authored 258 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Pulmonary and Respiratory Medicine, 136 papers in Physiology and 38 papers in Molecular Biology. Recurrent topics in Anders Eklúnd's work include Sarcoidosis and Beryllium Toxicity Research (109 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (103 papers) and Drug-Induced Adverse Reactions (26 papers). Anders Eklúnd is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (109 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (103 papers) and Drug-Induced Adverse Reactions (26 papers). Anders Eklúnd collaborates with scholars based in Sweden, United States and Norway. Anders Eklúnd's co-authors include Johan Grünewald, Olle Olerup, C. Magnus Sköld, Lars Klareskog, Johan Askling, Susanna Kullberg, Hans Wigzell, Leonid Padyukov, Jan Wahlström and Susanne Gabrielsson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Anders Eklúnd

254 papers receiving 11.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination

2005 1.1k citations Johan Grünewald, Anders Eklúnd et al. profile →
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders.

1999 1.0k citations Ulrich Costabel, Anders Eklúnd et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Anders Eklúnd	5.6k	5.4k	2.3k	1.8k	1.8k	258	11.3k
Johan Grünewald	5.2k 0.9×	5.3k 1.0×	2.4k 1.0×	2.0k 1.1×	2.3k 1.3×	269	11.3k
B. Wallaert	5.4k 1.0×	4.9k 0.9×	1.1k 0.5×	1.2k 0.7×	2.0k 1.1×	404	11.4k
William R. Henderson	3.7k 0.7×	4.6k 0.8×	2.9k 1.3×	742 0.4×	4.0k 2.2×	215	14.0k
Philippe Gosset	2.7k 0.5×	3.5k 0.6×	2.6k 1.1×	566 0.3×	3.2k 1.8×	289	10.8k
Joachim Müller‐Quernheim	6.4k 1.1×	5.4k 1.0×	1.6k 0.7×	734 0.4×	1.1k 0.6×	233	9.4k
Gary W. Hunninghake	13.4k 2.4×	8.7k 1.6×	4.6k 2.0×	1.4k 0.8×	4.7k 2.7×	273	24.9k
Kerstin Amann	3.3k 0.6×	2.1k 0.4×	6.7k 2.9×	1.5k 0.8×	4.3k 2.5×	584	24.4k
Christopher J. Corrigan	5.3k 0.9×	12.6k 2.3×	1.4k 0.6×	1.1k 0.6×	7.6k 4.3×	242	18.2k
Marc Peters‐Golden	4.7k 0.8×	4.6k 0.9×	4.9k 2.1×	531 0.3×	4.7k 2.7×	274	17.3k
Martin Kolb	10.6k 1.9×	2.8k 0.5×	2.7k 1.2×	1.1k 0.6×	1.2k 0.7×	279	14.9k

Countries citing papers authored by Anders Eklúnd

Since Specialization

Citations

This map shows the geographic impact of Anders Eklúnd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Eklúnd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Eklúnd more than expected).

Fields of papers citing papers by Anders Eklúnd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Eklúnd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Eklúnd. The network helps show where Anders Eklúnd may publish in the future.

Co-authorship network of co-authors of Anders Eklúnd

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Eklúnd. A scholar is included among the top collaborators of Anders Eklúnd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Eklúnd. Anders Eklúnd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rossides, Marios, Susanna Kullberg, Daniela Di Giuseppe, et al.. (2021). Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective ‘target trial’ emulated with Swedish real‐world data. Respirology. 26(5). 452–460. 24 indexed citations

Lepzien, Rico, Sang Liu, Paulo Czarnewski, et al.. (2021). Monocytes in sarcoidosis are potent tumour necrosis factor producers and predict disease outcome. European Respiratory Journal. 58(1). 2003468–2003468. 31 indexed citations

Rossides, Marios, Susanna Kullberg, Johan Grünewald, et al.. (2021). Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden. Heart. 108(6). 467–473. 14 indexed citations

Rossides, Marios, Susanna Kullberg, Johan Askling, et al.. (2020). Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case–control study. European Journal of Epidemiology. 35(11). 1087–1097. 12 indexed citations

Rossides, Marios, Susanna Kullberg, Anders Eklúnd, et al.. (2020). Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study. European Respiratory Journal. 56(3). 2000767–2000767. 29 indexed citations

Rossides, Marios, Susanna Kullberg, Anders Eklúnd, Johan Grünewald, & Elizabeth V. Arkema. (2019). Sarcoidosis diagnosis and treatment in Sweden: A register-based assessment of variations by region and calendar period. Respiratory Medicine. 161. 105846–105846. 16 indexed citations

Rossides, Marios, Johan Grünewald, Anders Eklúnd, et al.. (2018). Familial aggregation and heritability of sarcoidosis: a Swedish nested case−control study. European Respiratory Journal. 52(2). 1800385–1800385. 52 indexed citations

Rossides, Marios, Susanna Kullberg, Johan Askling, et al.. (2018). Sarcoidosis mortality in Sweden: a population-based cohort study. European Respiratory Journal. 51(2). 1701815–1701815. 63 indexed citations

Parasa, Venkata Ramanarao, Helena Forsslund, D. Lorenz, et al.. (2017). Enhanced CD8+ cytolytic T cell responses in the peripheral circulation of patients with sarcoidosis and non-Löfgren's disease. Respiratory Medicine. 138. S38–S44. 20 indexed citations

10.

Darlington, Pernilla, Leif Tallstedt, Leonid Padyukov, et al.. (2011). HLA-DRB1* alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis. European Respiratory Journal. 38(5). 1151–1157. 49 indexed citations

11.

Grünewald, Johan, Anders Eklúnd, & Olle Olerup. (2003). Human Leukocyte Antigen Class I Alleles and the Disease Course in Sarcoidosis Patients. American Journal of Respiratory and Critical Care Medicine. 169(6). 696–702. 119 indexed citations

12.

Katchar, Kianoosh, Jan Wahlström, Anders Eklúnd, & Johan Grünewald. (2001). Highly Activated T-Cell Receptor AV2S3+ CD4+ Lung T-Cell Expansions in Pulmonary Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 163(7). 1540–1545. 57 indexed citations

13.

Wahlström, Jan, Kianoosh Katchar, Hans Wigzell, et al.. (2001). Analysis of Intracellular Cytokines in CD4+ and CD8+ Lung and Blood T Cells in Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 163(1). 115–121. 131 indexed citations

14.

Grünewald, Johan, M Berlin, Olle Olerup, & Anders Eklúnd. (2000). Lung T-Helper Cells Expressing T-cell Receptor AV2S3 Associate with Clinical Features of Pulmonary Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 161(3). 814–818. 60 indexed citations

15.

Askling, Johan, Johan Grünewald, Anders Eklúnd, Gunnar Hillerdal, & Anders Ekbom. (1999). Increased Risk for Cancer Following Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 160(5). 1668–1672. 202 indexed citations

16.

Agerberth, Birgitta, Johan Grünewald, Esmeralda Castaños‐Vélez, et al.. (1999). Antibacterial Components in Bronchoalveolar Lavage Fluid from Healthy Individuals and Sarcoidosis Patients. American Journal of Respiratory and Critical Care Medicine. 160(1). 283–290. 144 indexed citations

17.

Wahlström, J., M Berlin, Rune Lundgren, et al.. (1997). Lung and blood T-cell receptor repertoire in extrinsic allergic alveolitis. European Respiratory Journal. 10(4). 772–779. 43 indexed citations

18.

Berlin, M, Anna Fogdell‐Hahn, Olle Olerup, Anders Eklúnd, & Johan Grünewald. (1997). HLA-DR Predicts the Prognosis in Scandinavian Patients with Pulmonary Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 156(5). 1601–1605. 198 indexed citations

19.

Costabel, Ulrich, Roland du Bois, Anders Eklúnd, et al.. (1994). Consensus conference: activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993. European Respiratory Journal. 7(3). 624–627. 61 indexed citations

20.

Sandström, Thomas, N Stjernberg, Anders Eklúnd, et al.. (1991). Inflammatory cell response in bronchoalveolar lavage fluid after nitrogen dioxide exposure of healthy subjects: a dose-response study. European Respiratory Journal. 4(3). 332–339. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact